SCHEMBL3487783

SCHEMBL3487783

CCN(CC)OC(c1ccccc1)(c1ccccc1)c1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KIF11 P52732 1/20 0.41
KCNN4 O15554 2/20 0.39
MAPK1 P28482 1/20 0.38
MEN1 O00255 3/20 0.38
KMT2A Q03164 3/20 0.38
KDM4E B2RXH2 1/20 0.38
SIGMAR1 Q99720 1/20 0.37
CHRM2 P08172 2/20 0.37
CHRM1 P11229 2/20 0.37
CHRM3 P20309 2/20 0.37
CHRM4 P08173 1/20 0.37
CHRM5 P08912 1/20 0.37
LMNA P02545 1/20 0.37
TSHR P16473 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
NPY2R P49146 1/20 0.36
POLB P06746 1/20 0.36
TAAR1 Q96RJ0 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22928368 0.88 KIF11 (0.46) KIF11LMNA
SCHEMBL1778576 0.81 TSHR (0.35) KIF11KCNN4MEN1KMT2AKDM4E
SCHEMBL8958019 0.75 CHRM2 (0.42) KCNN4MEN1KMT2AKDM4ESIGMAR1
SCHEMBL27602692 0.75 KCNN4 (0.48) KIF11KCNN4MAPK1MEN1KMT2A
SCHEMBL2350021 0.70 KIF11 (0.56) KIF11KCNN4MAPK1TAAR1ALDH1A1
SCHEMBL2348691 0.68 KIF11 (0.65) KIF11KCNN4MAPK1MEN1KMT2A
SCHEMBL6566849 0.67 MAPK1 (0.44) KIF11KCNN4MAPK1MEN1KMT2A
Methoxytriphenylmethane SCHEMBL9103 0.66 MAPK1 (0.48) KIF11KCNN4MAPK1TSHRTAAR1
SCHEMBL6752042 0.65 L3MBTL1 (0.45) MAPK1LMNATSHR
SCHEMBL10745740 0.65 KCNN4 (0.54) KCNN4MAPK1MEN1KMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9622959-B2 Cross-linked polymere CLARIANT INTERNATIONAL LTD. (CH) 2017-04-18 US disclosed
US-20140127147-A1 Cross-linked Polymere CLARIANT FINANCE (BVI) LIMITED (VG) 2014-05-08 US disclosed
CN-101802097-B Phosphoric acid esters containing phosphorus atoms bridged by diol units CLARIANT FINANCE BVI LTD 2012-11-14 CN disclosed
CN-101802096-B Aqueous compositions containing alkoxylated phosphoric triesters CLARIANT FINANCE BVI LTD 2012-07-18 CN disclosed
CN-1906204-B Flavonoid complexes comprising cyclodextrins MERCK PATENT GMBH 2012-05-09 CN disclosed
CN-1960699-B Keratin binding polypeptides BASF AG (DE) 2011-12-28 CN disclosed
CN-101802096-A Aqueous compositions containing alkoxylated phosphoric triesters CLARIANT FINANCE BVI LTD 2010-08-11 CN disclosed
CN-101802097-A Phosphoric acid esters containing phosphorus atoms bridged by diol units CLARIANT FINANCE BVI LTD 2010-08-11 CN disclosed
US-20100047296-A1 Low-Residue Cosmetic Or Dermatological Stick Based On An Oil-In-Water Dispersion/Emulsion III HENKEL AG & CO. KGAA (DE) 2010-02-25 US disclosed
CN-101588722-A The antimicrobial compositions that comprises zinc oxide, barium sulfate and silver ion MERCK PATENT GMBH (DE) 2009-11-25 CN disclosed
CN-100519666-C Silicon dioxide-coated nanoparticulate UV protectant MERCK PATENT GMBH SACHTLEBEN C (DE) 2009-07-29 CN disclosed
CN-1960699-A Keratin binding polypeptides BASF AG (DE) 2007-05-09 CN disclosed
CN-1938289-A Chromone complexes MERCK PATENT GMBH (DE) 2007-03-28 CN disclosed
CN-1906204-A Flavonoid complexes comprising cyclodextrins MERCK PATENT GMBH (DE) 2007-01-31 CN disclosed
CN-1826389-A Nanoparticulate UV protectant with silica coating MERCK PATENT GMBH (DE) 2006-08-30 CN disclosed
CN-1777653-A Antimicrobial pigments. MERCK PATENT GMBH (DE) 2006-05-24 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140127147-A1 Cross-linked Polymere PCNA, SMC2, SMC1A KIF11 2440/4885KCNN4 1958/4885MAPK1 575/4885
US-20100047296-A1 Low-Residue Cosmetic Or Dermatological Stick Based On An Oil-In-Water Dispersion/Emulsion III TYR, POLR1C, CUTA KIF11 2275/4885KCNN4 4198/4885MAPK1 3529/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.